Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 174883

Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology


Hitrec, Vlasta; Fučić, Aleksandra; Lasan, Ružica
Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology // Health Insurance in Transition:Biotechnology and Public Health: Expectations, Gains and Costs
Zagreb, 2002. (predavanje, međunarodna recenzija, sažetak, stručni)


CROSBI ID: 174883 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology

Autori
Hitrec, Vlasta ; Fučić, Aleksandra ; Lasan, Ružica

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Health Insurance in Transition:Biotechnology and Public Health: Expectations, Gains and Costs / - Zagreb, 2002

Skup
5th International Conference Health Insurance in Transition ; Biotechnology and Public Health: Expectations, Gains and Costs

Mjesto i datum
Zagreb, Hrvatska, 26-28. 09

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Clinical cytogenetics; Genetical toxicology

Sažetak
For the last few decades genetical toxicology has been relying on unstable biomarkers such as chromosome aberrations, micronucleus frequency and sister chromated exchange frequency as indicator of genome damage after exsposure to mutagenic and carcinogenic agents. Although the basic aim of genetical toxicology is to evaluate the risk of cancer development, stable aberrations (translocations, inversions, deletions) critical in carcinogenesis have not been detected due to lack of sutible methods. The collaboration between clinical cytogenetics and genetical toxicology confirms mimportance of translocations.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0108027

Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Vlasta Hitrec (autor)


Citiraj ovu publikaciju:

Hitrec, Vlasta; Fučić, Aleksandra; Lasan, Ružica
Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology // Health Insurance in Transition:Biotechnology and Public Health: Expectations, Gains and Costs
Zagreb, 2002. (predavanje, međunarodna recenzija, sažetak, stručni)
Hitrec, V., Fučić, A. & Lasan, R. (2002) Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology. U: Health Insurance in Transition:Biotechnology and Public Health: Expectations, Gains and Costs.
@article{article, author = {Hitrec, Vlasta and Fu\v{c}i\'{c}, Aleksandra and Lasan, Ru\v{z}ica}, year = {2002}, pages = {61}, keywords = {Clinical cytogenetics, Genetical toxicology}, title = {Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology}, keyword = {Clinical cytogenetics, Genetical toxicology}, publisherplace = {Zagreb, Hrvatska} }
@article{article, author = {Hitrec, Vlasta and Fu\v{c}i\'{c}, Aleksandra and Lasan, Ru\v{z}ica}, year = {2002}, pages = {61}, keywords = {Clinical cytogenetics, Genetical toxicology}, title = {Improving of biomonitoring strategy trough collaboration of clinical cytogenetics with genetical toxicology}, keyword = {Clinical cytogenetics, Genetical toxicology}, publisherplace = {Zagreb, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font